Dalbavancin is thermally stable at clinically relevant temperatures against methicillin-sensitive <i>Staphylococcus Aureus</i>

Hoyt, Aaron K.; Lawler, Patrick; Bostrom, Mathias; Carli, Alberto V.; Levack, Ashley E.

doi:https://doi.org/10.5194/jbji-8-175-2023

Articles | Volume 8, issue 3

https://doi.org/10.5194/jbji-8-175-2023

© Author(s) 2023. This work is distributed under
the Creative Commons Attribution 4.0 License.

https://doi.org/10.5194/jbji-8-175-2023

© Author(s) 2023. This work is distributed under
the Creative Commons Attribution 4.0 License.

Articles | Volume 8, issue 3

Original full-length article

|

28 Jun 2023

Original full-length article |

| 28 Jun 2023

Dalbavancin is thermally stable at clinically relevant temperatures against methicillin-sensitive Staphylococcus Aureus

Aaron K. Hoyt, Patrick Lawler, Mathias Bostrom, Alberto V. Carli, and Ashley E. Levack

Related authors

Changing the definition of treatment success alters treatment outcomes in periprosthetic joint infection: a systematic review and meta-analysis

Eytan M. Debbi, Tyler Khilnani, Ioannis Gkiatas, Yu-Fen Chiu, Andy O. Miller, Michael W. Henry, and Alberto V. Carli

J. Bone Joint Infect., 9, 127–136, https://doi.org/10.5194/jbji-9-127-2024,https://doi.org/10.5194/jbji-9-127-2024, 2024

Short summary

Do one-stage indications predict success following two-stage arthroplasty for chronic periprosthetic joint infection?

Michael M. Kheir, Christopher G. Anderson, Yu-Fen Chiu, and Alberto V. Carli

J. Bone Joint Infect., 9, 75–85, https://doi.org/10.5194/jbji-9-75-2024,https://doi.org/10.5194/jbji-9-75-2024, 2024

Short summary

Ceramic composite with gentamicin decreases persistent infection and increases bone formation in a rat model of debrided osteomyelitis

Aleksey Dvorzhinskiy, Giorgio Perino, Robert Chojnowski, Marjolein C. H. van der Meulen, Mathias P. G. Bostrom, and Xu Yang

J. Bone Joint Infect., 6, 283–293, https://doi.org/10.5194/jbji-6-283-2021,https://doi.org/10.5194/jbji-6-283-2021, 2021

Short summary

Related subject area

Subject: Biomaterials | Topic: All topics

Systemic rifampicin shows accretion to locally implanted hydroxyapatite particles in a rat abdominal muscle pouch model

Sujeesh Sebastian, Jintian Huang, Yang Liu, Mattias Collin, Magnus Tägil, Deepak Bushan Raina, and Lars Lidgren

J. Bone Joint Infect., 8, 19–28, https://doi.org/10.5194/jbji-8-19-2023,https://doi.org/10.5194/jbji-8-19-2023, 2023

Short summary

Fabrication of antibiotic-loaded dissolvable calcium sulfate beads: an in vitro mixing lab utilizing various antibiotic mixing formulas

Edward J. McPherson, Matthew V. Dipane, Madhav Chowdhry, and Andrew J. Wassef

J. Bone Joint Infect., 6, 405–412, https://doi.org/10.5194/jbji-6-405-2021,https://doi.org/10.5194/jbji-6-405-2021, 2021

Short summary

Cited articles

Almangour, T. A., Perry, G. K., Terriff, C. M., Alhifany, A. A., and Kaye, K. S.: Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility, Diagn. Microbiol. Infect. Dis., 93, 213–218, https://doi.org/10.1016/j.diagmicrobio.2018.10.007, 2019.

Appelbaum, P. C.: Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA), Int. J. Antimicrob. Agents, 30, 398–408, https://doi.org/10.1016/j.ijantimicag.2007.07.011, 2007.

Berend, K. R., Lombardi Jr., A. V., Morris, M. J., Bergeson, A. G., Adams, J. B., and Sneller, M. A.: Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality, Clin. Orthop. Relat. Res., 471, 510–518, https://doi.org/10.1007/s11999-012-2595-x, 2013.

Biedenbach, D. J., Ross, J. E., Fritsche, T. R., Sader, H. S., and Jones, R. N.: Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States, J. Clin. Microbiol., 45, 998–1004, https://doi.org/10.1128/JCM.02368-06, 2007.

Biedenbach, D. J., Bell, J. M., Sader, H. S., Turnidge, J. D., and Jones, R. N.: Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates, Antimicrob. Agents Chemother., 53, 1260–1263, https://doi.org/10.1128/AAC.01453-08, 2009.